$-0.22 EPS Expected for AtriCure, Inc. (ATRC)

October 14, 2018 - By Ellis Scott

AtriCure, Inc. (NASDAQ:ATRC) LogoInvestors sentiment increased to 1.38 in 2018 Q2. Its up 0.60, from 0.78 in 2018Q1. It increased, as 7 investors sold AtriCure, Inc. shares while 30 reduced holdings. 13 funds opened positions while 38 raised stakes. 28.28 million shares or 5.97% more from 26.69 million shares in 2018Q1 were reported.
56,900 are owned by Swiss Bancorporation. Alphaone Invest Service Llc has 1.47% invested in AtriCure, Inc. (NASDAQ:ATRC). Bancorp Of Montreal Can stated it has 39,143 shares. Zurcher Kantonalbank (Zurich Cantonalbank) has 0% invested in AtriCure, Inc. (NASDAQ:ATRC). Loomis Sayles Co Limited Partnership has invested 0.05% in AtriCure, Inc. (NASDAQ:ATRC). 89,664 were reported by Macquarie Grp Ltd. Voya Inv Mngmt Ltd stated it has 13,882 shares or 0% of all its holdings. D E Shaw owns 214,298 shares or 0.01% of their US portfolio. Invesco holds 0% of its portfolio in AtriCure, Inc. (NASDAQ:ATRC) for 17,374 shares. Morgan Stanley holds 160,328 shares or 0% of its portfolio. Piedmont Investment Advsrs Lc owns 582 shares. Bnp Paribas Arbitrage Sa owns 1,245 shares or 0% of their US portfolio. Wells Fargo And Mn stated it has 0% in AtriCure, Inc. (NASDAQ:ATRC). Neuberger Berman Grp Inc Lc accumulated 0.02% or 760,526 shares. Balyasny Asset Mgmt Ltd Liability Corp has invested 0% in AtriCure, Inc. (NASDAQ:ATRC).

Since May 7, 2018, it had 0 insider purchases, and 4 sales for $493,930 activity. Shares for $228,200 were sold by Krell Elizabeth D. Noznesky Justin J also sold $121,280 worth of AtriCure, Inc. (NASDAQ:ATRC) shares.

Analysts expect AtriCure, Inc. (NASDAQ:ATRC) to report $-0.22 EPS on November, 7.They anticipate $0.00 EPS change or 0.00 % from last quarter’s $-0.22 EPS. After having $-0.19 EPS previously, AtriCure, Inc.’s analysts see 15.79 % EPS growth. The stock increased 3.67% or $1.1 during the last trading session, reaching $31.11. About 446,775 shares traded or 105.47% up from the average. AtriCure, Inc. (NASDAQ:ATRC) has risen 68.55% since October 14, 2017 and is uptrending. It has outperformed by 52.93% the S&P500.

AtriCure, Inc. (NASDAQ:ATRC) Ratings Coverage

Among 4 analysts covering Atricure (NASDAQ:ATRC), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. Atricure had 8 analyst reports since April 27, 2018 according to SRatingsIntel. The rating was maintained by Canaccord Genuity on Wednesday, June 27 with “Buy”. The firm has “Buy” rating given on Friday, April 27 by Needham. The company was maintained on Monday, June 18 by Needham. The firm has “Buy” rating by Stifel Nicolaus given on Friday, April 27. The firm has “Buy” rating by Needham given on Wednesday, June 27. The company was maintained on Tuesday, October 9 by Canaccord Genuity. The company was maintained on Wednesday, June 27 by Stifel Nicolaus.

AtriCure, Inc. provides atrial fibrillation solutions to medical centers in the United States and internationally. The company has market cap of $1.18 billion. The firm offers Isolator Synergy and Isolator Synergy Access clamps for the treatment of persistent and long-standing persistent atrial fibrillation concomitant to other open-heart surgical procedures, such as coronary artery bypass grafting and/or valve replacement or repair; COBRA Fusion surgical ablation system to combine bipolar temperature-controlled radio frequency energy control with monopolar energy; and EPi-Sense guided coagulation system used for the temporary cardiac signal sensing and recording during surgery. It currently has negative earnings. It also provides SUBTLE cannula, an access device and conduit for the ablation device and endoscope to enable a closed chest endoscopic approach; multifunctional pens that allow surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and linear ablation devices, which enable physicians to create an expanded cardiac ablation lesion set.

More important recent AtriCure, Inc. (NASDAQ:ATRC) news were published by: Nasdaq.com which released: “Why Chefs’ Warehouse, SMART Global Holdings, and AtriCure Jumped Today” on October 05, 2018, also Bizjournals.com published article titled: “These Cincinnati stocks took the biggest hit amid Dow’s worst loss since February”, Seekingalpha.com published: “AtriCure announces pricing of common stock” on October 05, 2018. More interesting news about AtriCure, Inc. (NASDAQ:ATRC) was released by: Nasdaq.com and their article: “Report: Developing Opportunities within Agree Realty, Lattice Semiconductor, American Outdoor Brands, Schneider …” with publication date: October 12, 2018.

AtriCure, Inc. (NASDAQ:ATRC) Ratings Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.